Cannabis Use: A Marker of Clinical Severity in Inflammatory Bowel Disease?

Inflamm Bowel Dis. 2024 Feb 1;30(2):322-323. doi: 10.1093/ibd/izad221.

Authors

Simon Erridge^{1

2}, Mikael H Sodergren^{1

2}

Affiliations

¹ Imperial College Medical Cannabis Research Group, Department of Surgery and Cancer, Imperial College London, London, UK.
² Sapphire Medical Clinics, London, UK.

PMID: 37738592
DOI: 10.1093/ibd/izad221

No abstract available

Publication types

Editorial
Comment

MeSH terms

Cannabinoids*
Cannabis*
Humans
Inflammatory Bowel Diseases* / diagnosis
Longitudinal Studies

Substances

Cannabinoids